Cambridge Cognition Holdings plc CANTAB® incorporated in population health platform

Dr Steven Powell, CEO, Cambridge Cognition, said: “Through this collaboration we hope to widen the distribution channels of our medical software products to an established customer base in the US healthcare market.”

Cambridge Cognition Holdings plc (LON: COG), which develops and markets digital solutions to assess brain health, is pleased to announced a commercial collaboration with digital health provider Healthy Amplified, which sees the Company’s CANTAB® technology incorporated into a newly launched population health platform.

Healthy Amplified bridges the communication gap between healthcare providers, trainers, parents and youth sports caregivers. The inclusion of the gold standard cognitive assessment technology expands its offering to adults, facilitating the standardised testing of cognitive abilities, with a specific focus on assessing traumatic brain injury, depression, and the early detection of cognitive impairment associated with Alzheimer’s disease.

Under the collaboration, Healthy Amplified will act as a reseller of CANTAB products in US health markets, anticipating full rollout of its population health platform across 35 US Metropolitan Markets by the end of 2018.

William H. Nelson, CEO, Healthy Amplified, said: “By incorporating leading neurocognitive CANTAB technology, we are advancing our mission to provide population health management solutions available for adult populations.”

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
Twitter
LinkedIn
Cambridge Cognition Holdings

More articles like this

Cambridge Cognition Holdings

Cambridge Cognition forms new Scientific Advisory Board

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, is pleased to announce the formation of a Scientific Advisory Board. This expert board will provide scientific guidance and valuable market insights, primarily focusing

Cambridge Cognition Holdings

Cambridge Cognition Holdings Changes its Auditor to Crowe UK LL

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that the Board has approved the appointment of Crowe UK LLP as the Group’s new external auditor following a competitive

Cambridge Cognition Holdings

Cambridge Cognition strengthens balance sheet with £3 million loan

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that the Company has obtained a £3.0 million loan from Claret European Specialty Lending Company III, S.à r.l.  Claret specialises in

Cambridge Cognition Holdings

Cambridge Cognition Holdings Revision to Explanatory Note

Cambridge Cognition (LON:COG), which develops and markets digital solutions to assess brain health, has announced that the explanatory note to Resolution 7 in the Notice of the Annual General Meeting (“AGM”) to be held on 28 June 2023

Cambridge Cognition Holdings

Cambridge Cognition publishes Annual Report and Accounts

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has confirmed that the Annual Report and Accounts for the year ended 31 December 2022 and the Notice of the Annual General

Cambridge Cognition Holdings

Cambridge Cognition growth strategy clearly paying off (VIDEO)

Cambridge Cognition Holdings plc (LON:COG) CEO Matthew Stork joins DirectorsTalk Interviews to discuss prelim results for the year ended 31 December 2022. In this interview Matthew talks us through the result highlights, explains how the the acquisitions